• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Editorial Staff
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter Telegram
Asian Pacific Journal of Cancer Prevention
Articles in Press
Current Issue
Journal Archive
Volume Volume 19 (2018)
Volume Volume 18 (2017)
Volume Volume 17 (2016)
Volume Volume 16 (2015)
Volume Volume 15 (2014)
Volume Volume 14 (2013)
Issue Issue 12
Issue Issue 11
Issue Issue 10
Issue Issue 9
Issue Issue 8
Issue Issue 7
Issue Issue 6
Issue Issue 5
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 13 (2012)
Volume Volume 12 (2011)
Volume Volume 11 (2010)
Volume Volume 10 (2009)
Volume Volume 9 (2008)
Volume Volume 8 (2007)
Volume Volume 7 (2006)
Volume Volume 6 (2005)
Volume Volume 5 (2004)
Volume Volume 4 (2003)
Volume Volume 3 (2002)
Volume Volume 2 (2001)
Volume Volume 1 (2000)
(2013). RNAi and miRNA in Viral Infections and Cancers. Asian Pacific Journal of Cancer Prevention, 14(12), 7045-7056.
. "RNAi and miRNA in Viral Infections and Cancers". Asian Pacific Journal of Cancer Prevention, 14, 12, 2013, 7045-7056.
(2013). 'RNAi and miRNA in Viral Infections and Cancers', Asian Pacific Journal of Cancer Prevention, 14(12), pp. 7045-7056.
RNAi and miRNA in Viral Infections and Cancers. Asian Pacific Journal of Cancer Prevention, 2013; 14(12): 7045-7056.

RNAi and miRNA in Viral Infections and Cancers

Article 1, Volume 14, Issue 12, December 2013, Page 7045-7056  XML PDF (1225 K)
Abstract
Since the first report of RNA interference (RNAi) less than a decade ago, this type of molecular interventionhas been introduced to repress gene expression in vitro and also for in vivo studies in mammals. Understandingthe mechanisms of action of synthetic small interfering RNAs (siRNAs) underlies use as therapeutic agents inthe areas of cancer and viral infection. Recent studies have also promoted different theories about cell-specifictargeting of siRNAs. Design and delivery strategies for successful treatment of human diseases are becomingmoreestablished and relationships between miRNA and RNAi pathways have been revealed as virus-host cellinteractions. Although both are well conserved in plants, invertebrates and mammals, there is also variabilityanda more complete understanding of differences will be needed for optimal application. RNA interference (RNAi) israpid, cheap and selective in complex biological systems and has created new insight sin fields of cancer research,genetic disorders, virology and drug design. Our knowledge about the role of miRNAs and siRNAs pathwaysin virus-host cell interactions in virus infected cells is incomplete. There are different viral diseases but fewantiviral drugs are available. For example, acyclovir for herpes viruses, alpha-interferon for hepatitis C and Bviruses and anti-retroviral for HIV are accessible. Also cancer is obviously an important target for siRNA-basedtherapies, but the main problem in cancer therapy is targeting metastatic cells which spread from the originaltumor. There are also other possible reservations and problems that might delay or even hinder siRNA-basedtherapies for the treatment of certain conditions; however, this remains the most promising approach for a widerange of diseases. Clearly, more studies must be done to allow efficient delivery and better understanding ofunwanted side effects of siRNA-based therapies. In this review miRNA and RNAi biology, experimental design,anti-viral and anti-cancer effects are discussed.
Keywords
RNA interference; micro RNA; antiviral agent- anticancer agent
Statistics
Article View: 448
PDF Download: 619
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

 



 

Journal Management System. Designed by sinaweb.